Although this model explains the metabolic phenotypes in several cancers, such as liver, brain, and pancreatic cancer50–52, it is not supported by clinical data from colon, breast, and lung cancers, in which LDHB is also abundant10,11,53. This evidence concerns the gene LDHB and lung carcinoma.